CAS 6493-06-7 (±)-Lisofylline - Analytical Products / Alfa Chemistry

CAT	AP6493067
CAS	6493-06-7
Structure
MDL Number	MFCD00871850
Molecular Weight	280.32
InChI Key	NSMXQKNUPPXBRG-UHFFFAOYSA-N

Description	analytical standard
Assay	≥99.0% (HPLC)
Grade	analytical standard
Size	25MG
Storage Conditions	−20°C

1

Lisofylline as a Modifier of Radiation Therapy

J S Wong, G Ara, S R Keyes, R Herbst, C N Coleman, B A Teicher

Oncol Res. 1996;8(12):513-8.

PMID: 9160355

1

Pharmacological Agents for Adults With Acute Respiratory Distress Syndrome

Sharon R Lewis, Michael W Pritchard, Carmel M Thomas, Andrew F Smith

Cochrane Database Syst Rev. 2019 Jul 23;7(7):CD004477.

PMID: 31334568

1

Randomized, Placebo-Controlled Trial of Lisofylline for Early Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

Crit Care Med. 2002 Jan;30(1):1-6.

PMID: 11902249

1

Raw Material Specification, Lisofylline, 60 mg/mL

NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee, NIH CIT Consortium

CellR4 Repair Replace Regen Reprogram. 2017;5(2):e2278.

PMID: 30613746

1

The Clinical Practice Guideline for the Management of ARDS in Japan

Satoru Hashimoto, Masamitsu Sanui, Moritoki Egi, Shinichiro Ohshimo, Junji Shiotsuka, Ryutaro Seo, Ryoma Tanaka, Yu Tanaka, Yasuhiro Norisue, Yoshiro Hayashi, Eishu Nango, ARDS clinical practice guideline committee from the Japanese Society of Respiratory Care Medicine and the Japanese Society of Intensive Care Medicine

J Intensive Care. 2017 Jul 25;5:50.

PMID: 28770093

* Products or Services Interested: (±)-Lisofylline (6493-06-7)
* Your question
* Name
* Email
Verification Code